Bicara Therapeutics Inc. BCAX
NASDAQ · United States · Health Technology
$18.58-0.03 (-0.16%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.82 | -0.82 | 0.0% | $0 | — | -11.2%$27.73→$24.63 |
| Q1 2026 | 2026-05-11 | -0.93 | -0.64 | -45.3% | — | — | -0.9%$22.58→$22.38 |
| Q4 2025 | 2026-03-30 | -0.68 | -0.65 | -4.6% | — | — | +8.3%$18.37→$19.89 |
| Q3 2025 | 2025-11-10 | -0.67 | -0.55 | -21.8% | — | — | +0.6%$14.64→$14.73 |
| Q4 2024 | 2025-03-27 | -0.39 | -0.28 | -39.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.